These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 21033246)
1. Very low density lipoprotein receptor subtype II silencing by RNA interference inhibits cell proliferation in hepatoma cell lines. Luo M; Liu YJ; Xia LM; Yan W; Zhu Q; Tian DA Hepatogastroenterology; 2010; 57(101):882-90. PubMed ID: 21033246 [TBL] [Abstract][Full Text] [Related]
2. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2]. Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068 [TBL] [Abstract][Full Text] [Related]
3. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro]. Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881 [TBL] [Abstract][Full Text] [Related]
4. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines. Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140 [TBL] [Abstract][Full Text] [Related]
5. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma. Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547 [TBL] [Abstract][Full Text] [Related]
6. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis. Sirach E; Bureau C; Péron JM; Pradayrol L; Vinel JP; Buscail L; Cordelier P Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668 [TBL] [Abstract][Full Text] [Related]
7. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth. Wang Z; Wei W; Sun CK; Chua MS; So S Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386 [TBL] [Abstract][Full Text] [Related]
8. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene. Wang B; Xunsun ; Liu JY; Yang D; Yang LL; Kong DX; Meng XW Hepatogastroenterology; 2012; 59(114):515-8. PubMed ID: 22024040 [TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effect of wild-type RASSF1A gene expression on proliferation of hepatocellular carcinoma QGY-7703 cells]. Rui L; Xue WJ; Li P; Wang ZW; Wang P; Li HX Ai Zheng; 2008 Sep; 27(9):924-8. PubMed ID: 18799029 [TBL] [Abstract][Full Text] [Related]
10. TFPI or uPA-PAI-1 complex affect cell function through expression variation of type II very low density lipoprotein receptor. Di Y; Liu Z; Tian J; Zong Y; Yang P; Qu S FEBS Lett; 2010 Aug; 584(15):3469-73. PubMed ID: 20624392 [TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2]. Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759 [TBL] [Abstract][Full Text] [Related]
12. Enhanced activity of very low density lipoprotein receptor II promotes SGC7901 cell proliferation and migration. Yang P; Liu Z; Wang H; Tian J; Li Y; Zong Y; Qu S Life Sci; 2009 Mar; 84(13-14):402-8. PubMed ID: 19167408 [TBL] [Abstract][Full Text] [Related]
13. [Effect of Na(+)/K(+)-ATPase alpha1 siRNA and ouabain upon cell cycle in human hepatoma HepG2 cell and its mechanism]. Xu ZW; Wang FM; Xu RC; Hu WL; Chen XY Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):813-7. PubMed ID: 20450619 [TBL] [Abstract][Full Text] [Related]
15. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor. Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503 [TBL] [Abstract][Full Text] [Related]
16. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County. Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489 [TBL] [Abstract][Full Text] [Related]
17. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression. Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173 [TBL] [Abstract][Full Text] [Related]
18. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference]. Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086 [TBL] [Abstract][Full Text] [Related]
19. Cyclosporine inhibits catabolism of low-density lipoproteins in HepG2 cells by about 25%. Rayyes OA; Wallmark A; Florén CH Hepatology; 1996 Sep; 24(3):613-9. PubMed ID: 8781333 [TBL] [Abstract][Full Text] [Related]
20. The effect of NET-1 on the proliferation, migration and endocytosis of the SMMC-7721 HCC cell line. Wang GL; Chen L; Wei YZ; Zhou JM; Wu YY; Zhang YX; Qin J; Zhu YY Oncol Rep; 2012 Jun; 27(6):1944-52. PubMed ID: 22378020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]